Medi-Span Price RX

The Department of Financial Services, Division of Workers’ Compensation in Florida is pursuing a non-competitive, single-source procurement to acquire an online subscription to Wolters Kluwer’s Medi-Span Price RX database, a proprietary drug pricing resource essential for calculating pharmaceutical reimbursement amounts in workers’ compensation claims. The contract, spanning from September 15, 2025, to September 14, 2028, is justified under Florida Statute 440.13(12)(h), which mandates the use of this specific database for accurate and standardized drug pricing. The initial license fee for fifteen users is estimated at approximately $180,358 annually, with provisions allowing up to five additional licenses per year, not exceeding a total contract value of around $236,356 over three years. The procurement emphasizes the proprietary and exclusive nature of the Medi-Span database, which is only available from Wolters Kluwer, making competitive sourcing infeasible. The contract includes detailed provisions for the performance period, licensing options, and cost caps, but does not specify FAR clauses or federal acquisition standards, as it is governed by Florida statutes and administrative rules. The procurement process involves submitting relevant information by December 16, 2025, via the state's Vendor Information Portal, with the agency’s primary contact being Chrisy Smith. The service is delivered electronically, with no physical goods involved, and performance acceptance is implied to occur at the agency’s location in Florida. The documentation underscores the statutory basis for sole-source justification, with no mention of evaluation factors, certifications, or detailed contractual clauses typical of federal procurements. Overall, this initiative ensures the continued use of a critical proprietary database to support fair and consistent pharmaceutical reimbursement within the state's workers’ compensation system.